ACHILLES THERAPEUTICS PLC's ticker is ACHL and the CUSIP is 00449L102. A total of 24 filers reported holding ACHILLES THERAPEUTICS PLC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $40,799 | – | 45,332 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Syncona Portfolio Ltd | 11,086,909 | $55,545,000 | 53.06% |
RA Capital Management | 5,014,687 | $25,124,000 | 0.44% |
Artal Group S.A. | 2,255,375 | $11,299,000 | 0.31% |
Redmile Group, LLC | 2,088,089 | $10,461,000 | 0.24% |
Orbimed Advisors | 1,584,845 | $7,940,000 | 0.10% |
Sender Co & Partners, Inc. | 27,690 | $139,000 | 0.07% |
Baker Brothers Advisors | 2,591,366 | $12,983,000 | 0.06% |
Perceptive Advisors | 1,510,750 | $7,568,000 | 0.06% |
Woodline Partners LP | 324,387 | $1,625,000 | 0.02% |
Point72 Asset Management, L.P. | 1,000,000 | $5,010,000 | 0.02% |